Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Aceclofenac in rheumatoid arthritis: A useful and novel anti-inflammatory

Summary

The efficacy and safety of 100 mg aceclofenac twice daily was investigated in 73 patients with active rheumatoid arthritis in a multi-centre, double blind, randomised, parallel group, placebo controlled study over a period of 4 weeks. Treatment with aceclofenac was effective in improving the Ritchie articular index (predetermined primary end point), duration of morning stiffness, joint swelling, ARA functional class, patient's and physician's global assessments, and pain. All these improved to a significantly (P<0.05) greater extent than in placebo-treated patients. Grip strength showed a significant improvement from baseline in the aceclofenac-treated group and this was greater than the improvement measured in placebo treated patients. No significant difference was detected between the treatment groups for the number of subjects reporting an adverse event. Aceclofenac administered orally at 100 mg twice daily for four weeks thus produced significant improvements in patients with active rheumatoid arthritis. This treatment was well tolerated with an adverse event profile similar to that of placebo.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Weisman, M.H. Corticosteroids in the treatment of rheumatologic diseases. Curr Opinion Rheumatol 1995, 7, 183–190.

  2. 2.

    Bijlsma, J.W.J., van Everdingen, A.A., Jacobs, J.W.G. Corticosteroids in rheumatoid arthritis: How best to use them? Clin Immunother 1995, 3, 271–286.

  3. 3.

    Brooks, P.M., Kean, W.F., Buchanan, W.W. The Clinical Pharmacology of Anti-Inflammatory Agents. London and Philadelphia, Eds.: Taylor and Francis, 1986.

  4. 4.

    Turner, R.A. Arthritis update — nonsteroidal anti-inflammatory agents in the therapy of rheumatoid arthritis. Drugs of Today 1989, 25, 373–381.

  5. 5.

    Lanza, F.L. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 1993, 88, 1318–1323.

  6. 6.

    Grau, M., Guasch, J., Montero, J.L., Felipe, A., Carrasco, E., Julia, S. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Arzneim-Forsch/Drug Res 1991, 41, 1265–1276.

  7. 7.

    Sains Olalla, F. Analgesic efficacy of aceclofenac, double-blind controlled study vs placebo in odontalgia. Curr Therap Res 1988, 43, 900–902.

  8. 8.

    Bubani, G. The analgesic activity and tolerability of aceclofenac in the treatment of odontalgia. Clin Trials J 1988, 25, 244–246.

  9. 9.

    Movilia, P.G. Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of post-episiotomy pain. Drugs Exptl Clin Res 1989, 15, 47–51.

  10. 10.

    Yscla, A. Aceclofenac and paracetamol in episiotomal pain. Drugs Exptl Clin Res 1988, 14, 491–494.

  11. 11.

    Grupo De Estudio De Atthritis Reumatoide. Effectiveness and tolerance of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Rev Esp Reumathol 1992, 19, 263–68.

  12. 12.

    Ballesteros, R., Ansoleaga, J.J., Tapounet, R. The efficacy and tolerance of aceclofenac in rheumatoid arthritis. Clin Trials J 1990, 27, 12–19.

  13. 13.

    Giorgianni, G., Ottaviani, C., Soliano, A., Campi, N. Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curr Therap Res 1992, 51, 175–84.

  14. 14.

    Birell, D.H., Roma, J., Bowdler, J.M. Evaluation of the efficacy and safety of aceclofenac in the treatment of osteoarthritis. Br J Clin Res 1995, 6, 45–55.

  15. 15.

    Ward, D.E., Veys, E.M., Bowdler, J.M. Roma, J. Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis. Clin Rheumatol 1995, in press.

  16. 16.

    Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsger, T.A., Mitchell, D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., Sharp, J.T., Wilder, R.L., Hunder, G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 1988, 31, 315–324.

  17. 17.

    Ritchie, D.M., Boyle, J.A., Mc Innes, J.M., Jasani, M.E., Dalakos, T.G., Grieveson, P., Buchanan, W.W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart J Med 1968, 37, 393–406.

  18. 18.

    Steinbrocker, O., Traeger, Ch., Batterman, R.C. Therapeutic criteria in rheumatoid arthritis. J Amer Med Assoc 1949, 140, 659–662.

  19. 19.

    Martín-Mola, E., Gijàon-Baños, J., Ansoleaga, J.J. Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol Int 1995, 15, 111–116.

  20. 20.

    Hart, F.D. Rational use of analgesics in the treatment of rheumatic disoreders. Drugs 1987, 33, 85–93.

  21. 21.

    Dajani, E.Z., AGrawal, N.M. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. An update. J Physiol Pharmacol 1995, 46, 3–16.

  22. 22.

    Wassif, W., Bjarnason, I. A Comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss. Br J Clin Res 1992, 3, 109–114.

Download references

Author information

Correspondence to Dr. X. Gras I Balaguer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hunter, J.A., Parnham, M.J. & Balaguer, X.G.I. Aceclofenac in rheumatoid arthritis: A useful and novel anti-inflammatory. Clin Rheumatol 15, 329–334 (1996). https://doi.org/10.1007/BF02230353

Download citation

Key words

  • Rheumatoid Arthritis
  • Anti-inflammatory Drug Therapy
  • Aceclofenac